SRS Capital Advisors »

Immunome shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 120 11.72
2025-03-31 $464 69 6.74

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Redmile Group
Vanguard Group
Point72 Asset Management
Enavate Sciences GP
Leucadia National Corporation
EcoR1 Capital
Opaleye Management
PRIMECAP Management Company
State Street Corporation
Caption Management
Toronto-Dominion Bank
Geode Capital Management

View all funds holding Immunome